COMMUNITY HEALTH NURSING 1
LECTURE NOTES
NATIONAL HEALTH IMMUNIZATION PROGRAM
Immunization is a global health and development success story, saving millions of lives
every year. Vaccines reduce risks of getting a disease by working with your body’s natural defenses
to build protection. When you get a vaccine, your immune system responds.
Immunization is a key component of primary health care and an indisputable human right.
It’s also one of the best health investments money can buy. Vaccines are also critical to the
prevention and control of infectious-disease outbreaks. They underpin global health security and will
be a vital tool in the battle against antimicrobial resistance.
Is one of the pioneering programs of the DOH programs that have already been
institutionalized and adopted by all local government units (LGU) in the country
Just two years after the WHO established the program in 1974, the Philippines followed
establishing free vaccination against 6 common diseases
Its objective is to reduce infant mortality and morbidity through decreasing the prevalence of
the seven (7) immunizable diseases (TB, diphtheria, pertussis, tetanus, polio, hepatitis B and
measles)
Why is there a need to vaccinate?
Because vaccines save lives
Protects children from vaccine preventable diseases that once were top killers and
disablers worldwide
Good health promotes social development and economic growth
Immunization is a basic right of the child and therefore no child shall be deprived of this
right
Legal Basis of NIP
The fundamental law of the land – the 1987 Philippine Constitution – says that “The state
shall adopt a comprehensive approach to health development which shall endeavor to make
essential goods, health and other social services available to all people at affordable cost.
There shall be priority for the needs of the underprivileged, sick, elderly, disabled, women and
children” (Article 13, Sec. 11)
Presidential Decree No. 996 (September 16, 1976) – provides for compulsory
immunization for infants and children age 8 years old and below of the 6 immunizable
diseases (TB, diphtheria, pertussis, tetanus, polio, and measles)
Presidential Proclamation No. 6 – implementing the Expanded Program on
Immunization (EPI) in response to the United Nation’s goal of Universal Child
Immunization by 1990
Proclamation No. 46 (September 16, 1992) – reaffirmed the Philippines’ commitment
to universal goal of eradicating polio by 2000 through child and mother immunization
RA No 7846 – an act requiring compulsory immunization against Hepatitis B for
infants and children below 8 years old
These include vaccination against: Tuberculosis (TB), Diphtheria, Pertussis,
Tetanus (DPT), Poliomyelitis (administered orally), Measles, Rubella, Hepatitis B in
newborns within 24 hours after birth, and Provision of other basic immunization
services for infants and children below 8 years old
DOH Administrative Order No. 39, s 2003 (April 21, 2003) – guided the nationwide
implementation of the EPI
RA 10152 (July 2, 2011)– an act providing for mandatory basic immunization services
for infants and children, repealing for the purpose PD 996
Mandatory Infants and Children Health Immunization Act of 2011
Mandatory Infants and Children Health Immunization Act of 2011 (RA 10152)
The Mandatory basic immunization for all infants and children of the following
vaccine-preventable diseases:
◦ Tuberculosis
◦ Diphtheria, pertussis and tetanus
◦ Poliomyelitis
◦ Measles (Rubeola)
◦ Mumps
◦ Rubella or German measles
◦ Hepatitis B
◦ H. Influenza Type B (HIB)
◦ Other types as may be determined by the Secretary of Health in a
department circular
◦ The mandatory immunization shall be given for free at any government hospital or
health centers to infants and children up to 5 years of age
RA 7846 – provided for compulsory immunization against Hepatitis B for infants and children
below 8 years old.
◦ It also provided for Hepatitis B immunization within 24 hours after birth of babies of
women with hepatitis B
What is immunization?
Process where a person is made resistant to an infectious disease through the
administration of a vaccine
Immunity
Passive Immunity
Acquired through administration of products from human or animals providing short
term protection (few weeks or months)
Active Immunity
Formed by stimulation of the immune system producing antibodies through exposure
to an infection and/or vaccination
Types of Vaccines
Live attenuated vaccines
Weakened or modified wild viruses or bacteria
uses a living but weakened version of the virus or one that’s very similar
Immunity through replication of the organism in the person
measles, mumps and rubella (MMR) vaccine and the chickenpox and shingles vaccine
are examples of this type of vaccine
BCG, OPV, MMR, JE
Inactivated Vaccines
Grown in media culture
Must contain sufficient antigenic mass to stimulate desired response since it is unable
to replicate inside the host
the disease-carrying virus or bacterium, or one very similar to it, and inactivate or kill
it using chemicals, heat or radiation
Viral Vector Vaccines
This type of vaccine uses a safe virus to deliver specific sub-parts – called proteins – of the
germ of interest so that it can trigger an immune response without causing disease
The safe virus then serves as a platform or vector to deliver the protein into the body.
The protein triggers the immune response.
The Ebola vaccine is a viral vector vaccine
Policy Statement
Immunization is a basic right of the child therefore no child shall be deprived of this right
The mandatory basic immunization shall be given FREE at any government hospital or
health center to infants and children up to five (5) years of age
Program Goals
Maintenance of at least 95% Fully Immunized Child (FIC) coverage
Maintenance of polio eradication
Elimination of measles
Elimination of maternal and neonatal tetanus
Control of Diphtheria, Pertussis, Hepatitis B infection, Tuberculous Meningitis and
other disseminated forms of TB
Basic Immunization Schedule
Giving of 1 dose of BCG at birth, birth dose of Hepatitis b vaccine, 3 doses of OPV, 3
doses of Pentavalent vaccine, 1 dose of MCV at 9 months and another 1 dose of
MCV at 10-12 months
= FULLY IMMUNIZED CHILD (FIC)
Tetanus Diphtheria Immunization Schedule for Women
Principles of NIP
Based on the epidemiological feature of the disease
Mass approach
Basic health service – given for free at the health center
Elements of NIP
Cold chain
Target setting
Information, education, communication (IEC)
Studies, surveillance and research
Evaluation
Goals of NIP
To immunize all infants/children against the most common vaccine-preventable
diseases
To sustain the polio-free status of the Philippines
To eliminate measles infection (Presidential Proc. No. 4 s. 1998 – Philippine Measles
Elimination Campaign)
To eliminate maternal and neonatal tetanus (Presidential Proc. No. 1066 s. 1997
declared a national neonatal tetanus elimination campaign starting 1997)
To control diphtheria, pertussis, hepatitis B and German measles
To prevent extrapulmonary TB among children
Important Consideration on the Schedule and Administration of Immunizations
Use only one sterile syringe and needle per client
There is no need to restart a vaccination series regardless of the time that has elapse
between doses
All EPI antigens are safe and effective when administered simultaneously, that is, during
same immunization session but at different sites
It is NOT recommended to mix different vaccines in one syringe before injection, or to
use a fluid vaccine for reconstitution of a freeze-dried vaccine
When a vaccine is administered to an infant at the same time with another injectable
vaccine, the vaccines should be administered on different sites
If more than one injection has to be given on the same limb, the injection sites should be
2.5-5cm apart to prevent overlapping of local reactions
The recommended sequence of the co-administration of vaccines is OPV first followed
by Rotavirus vaccine, then other appropriate vaccines
OPV is administered by putting drops of the vaccine straight from the dropper onto the
child’s tongue. Do not let the dropper touch the tongue
Only monovalent hepatitis B vaccine must be used for the birth dose. Pentavalent
vaccine must not be used for the birth dose because DPT and Hib vaccine should not
be given at birth
Children who have not received Anti-measles vaccine 1 (AMV1) as scheduled and
children whose parents or caregivers do not know whether they have received AMV1
shall be given AMV1 as soon as possible, then AMV2 one month after the AMV1 dose
All children entering day care centers/preschool and Grade 1 shall be screened for
measles immunization. Those without the immunization shall be referred to the nearest
health facility for immunization
The first dose of Rotavirus vaccine is administered only to infants aged 6 weeks to 15
weeks. The second dose is given only to infants aged 10 weeks up to a maximum of 32
weeks
Administer the entire dose of the Rotavirus vaccine slowly down one side of the mouth
(between the cheek and gum) with the tip of the applicator directed toward the back of
the infant’s mouth
Vaccine Preventable Diseases
EPIDEMIOLOGICAL FEATURE OF THE DISEASE
1. TUBERCULOSIS
Signs and Symptoms of Tuberculosis:
General weakness
Stunted growth
Failure to thrive
Loss of appetite
Weight loss
Fever
Chest pain
Night sweats
Cough, hemoptysis, chest pain
BCG (Bacillus Calmette-Guerin) Vaccine
Prevent milliary and meningeal TB in the first years of life
Protects infants infected with TB from progressing to more dangerous forms
Does not prevent TB itself; little protection against the pulmonary forms
Take Note: For BCG
TB negative mother: given to newborn preferably 90 minutes after birth
TB positive mother: given to newborn 1 month after a negative PPD Test
HIV Positive Baby: do not give BCG
Discard after 6 hours
2. HEPATITIS B
Signs and Symptoms of
Hepatitis B
Abdominal swelling
Abdominal bleeding
Jaundice
Vomiting
95% effective in preventing chronic infection
Monovalent, used as birth dose (within 24 hours); may be given within 7 days
Should never be frozen
3. POLIOMYELITIS
Signs and Symptoms of Poliomyelitis
Influenza-like symptoms:
◦ Fever, loose stools, sore throat, headache, upset stomach
Pain/stiffness in the neck, back
Paralysis
What is the presentation of inactivated poliovirus vaccine (IPV)?
Liquid suspension providing protection against all 3 types of poliovirus
Multi dose vials, 10 doses per vial
Does not require reconstitution
Preservatives in multi-dose vials of IPV do not meet WHO requirements to preserve the
vaccine for 28 days
Multi-dose vials of this vaccine must be discarded at the end of the immunization session
or within 6 hours after opening, whichever comes first
Vaccines OPV and IPV
3 doses of OPV and 1 dose of IPV produces immunity for all poliovirus types
With OPV, vaccine associated paralytic polio (VAPP) occurs in 1 in 2.7
million, and this is associated with immunodeficiency or immunocompromised
individuals
4. DIPHTHERIA
Signs and Symptoms of Diptheria
Sore throat, loss of appetite, fever
Bluish-white or grey membrane at the tonsils or pharynx
Pseudo membrane
Swollen throat “Bull Neck”
5. PERTUSSIS (Whooping Cough)
Pertussis Signs and Symptoms
Runny nose, watery eyes, fever, mild cough
Cough worsens to rapid bursts (high pitched whoop)
6. TETANUS
Agent Clostridium tetani
Reservoir Soil, animal intestines
Spread Spores enter through wound sites
Duration of community induced -
infection
Exposure to animal feces,
Risk Factor for Infection infections with rusty metals,
untreated wounds
Signs and Symptoms of Tetanus
Spasms and stiffness on jaw and muscles
Difficulty swallowing
Stiffness of abdominal muscles
Spasms are triggered by minor occurrences (air draft, loud noise, physical
touch, light
7. HAEMOPHILUS INFLUENZA TYPE B DISEASE
Agent Haemophilus Influenza Type B
Reservoir Humans
Spread Close Respiratory Contact
Duration of community induced Usually lifelong
infection
Risk Factor for Infection Crowding
Signs and Symptoms of Haemophilus Influenza Type B
Fever, chills, cough, rapid breathing, chest wall retractions
Meningitis: fever, headache, sensitivity to light, neck stiffness, confusion,
altered consciousness
8. PNEUMOCOCCAL DISEASE
Bacteria (Streptococcus
Agent
Pneumonae)
Reservoir Humans
Close Respiratory Contact,
Spread
Airborne Droplets
Duration of community induced Some type-specific immunity
infection
Risk Factor for Infection Crowding
Middle Ear Infection
(Otitis media), sinusitis,
and bronchitis (Mild case
– non-invasive)
Freeze-sensitive vaccine
Storage at +2 - +8
degrees Celsius
Postpone vaccination if
the child has moderate
to severe illness with
temp >39°C
Pneumococcal Polysaccharide
Vaccine (PPV)
- 1 dose for adults
9. MEASLES (RUBEOLA)
Agent Measles virus
Reservoir Humans
Close Respiratory Contacts,
Spread
Aerosolized Droplets
Duration of community induced Lifelong
infection
Risk Factor for Infection Crowding
Signs and Symptoms
Cough, coryza, conjunctivitis
Rash (cephalocaudal distribution)
Complications: pneumonia, otitis media
10. MUMPS
Agent Virus
Reservoir Humans
Close Respiratory Contact, Airborne
Spread
droplets
Duration of community induced Lifelong
infection
Risk Factor for Infection Crowding
Signs and Symptoms of Mumps
Swelling of salivary glands
Pain in chewing or swallowing
Fever
Testicular swelling and tenderness
11. GERMAN MEASLES (RUBELLA)
Agent Rubella Virus
Reservoir Humans
Close Respiratory Contact, Airborne
Spread
Droplets
Duration of community induced Lifelong
infection
Risk Factor for Infection Crowding
Signs and Symptoms
Usually mild in children and adults
3-day rash, fever
Complication: Congenital Rubella Syndrome
Deafness, cardiac defects, cataracts, mental retardation
Forchheimer Spots on the soft palate
For persons with German Measles
12. HUMAN PAPILLOMA VIRUS
Agent Human Papilloma Virus
Reservoir Humans
Spread Sexual Intercourse
Duration of community induced Not Known
infection
Risk Factor for Infection Unsafe Sexual Practices
Known to be the cause of 99% of cervical cancer
Infects skin and mucous membrane of the genital areas of men and women
Abnormal vaginal bleeding, vaginal discharges, fatigue, weight loss
Vaccine: HPV (Bivalent, Quadrivalent, Nonavalent)
Routinely given to females 9-10 years old
Given twice 6 months apart
13. INFLUENZA
Agent Virus
Reservoir Humans
Close Respiratory Contacts, Airborne
Spread
Droplets
Duration of community induced infection Unknown, Weak immunity
Risk Factor for Infection Crowding
Vaccine: Seasonal Influenza Vaccine
2 types: Trivalent and Quadrivalent
Adults 60 years of age or older should get vaccine ideally before flu season
(May-October)
14. JAPANESE ENCEPHALITIS
Agent Virus
Reservoir Mosquitoes
Spread Bite by infected mosquito
Duration of community induced Lifelong
infection
Presence of high burden disease
Risk Factor for Infection
causing vectors
Signs and Symptoms
Sudden onset of fever, chills, headache, nausea, vomiting
Gastrointestinal pain
Seizures
Vaccine: Japanese Encephalitis Vaccine (JEV)
4 types. Live attenuated – most commonly used
Single dose at less than 8 months old
Contraindications: pregnancy, immunodeficient individuals 9chronic disease,
congenital problems)
15. ROTAVIRUS GASTROENTERITIS
a. A highly infectious diarrheal disease caused by strains of rotavirus infecting small intestine
b. Rotaviruses are a leading cause of severe diarrheal disease and dehydration in infants and
young children throughout the world
c. Also called as the “stomach flu”
Signs and Symptoms
Mild loose stools to severe watery diarrhea and vomiting leading to dehydration
Fever and vomiting can occur before diarrhea
Incubation period can range from 1-3 days
Diarrhea can last from 3 days to 1 week
How is Rotavirus Transmitted?
Spreads by fecal to oral route
Large quantities of virus can be shed in the feces of an infected child
Shedding can occur from 2 days to 10 days after the onset of symptoms
Rotavirus is stable in the environment and can spread via contaminated food, water
and objects
How is Rotavirus Prevented?
Improved nutrition, good hygiene (handwashing) and sanitation
Two oral, live, weakened rotavirus vaccine: Rotarix™ and RotaTeq™ are available
internationally
Both are considered safe and effective in preventing gastrointestinal disease
Vaccine: Rotavirus Vaccine
Live, attenuated virus
Clear, colorless liquid in a container with an oral applicator
DIPHTHERIA-TETANUS VACCINE
Weakened toxin
Sometimes slightly turbid in appearance; clear, colorless liquid sometimes slightly
turbid
Damaged by heat or freezing
Store at +2 ºC to +8 ºC (body of the refrigerator)
Given to pregnant women to protect against tetanus and neonatal tetanus
The Shake Test
Compare the vaccine that you suspect has been frozen and thawed with vaccine from
the dame manufacturer that you are sure was never frozen:
1. Shake the containers of vaccine
2. Inspect the contents carefully
3. Leave the vaccines to stand side by side for 15-30 minutes for the sediments to
settle
4. Inspect the contents carefully again
Testing Tetanus-Diphtheria and Pentavalent Vaccine for Damage
TARGET SETTING
Vaccine requirement is calculated based on eligible population
The following formulas are used:
o Estimated number of infants = total population x 2.7%
o Estimated number of 12 to 59-month-old children = total population x 10.8%
o Estimated number of pregnant women = total population x 3.5%
Computation of Vaccine Requirements:
To compute vaccine requirements, use the following formula:
o Vaccine requirement for the year = eligible population x number of doses x wastage
multiplier
o The wastage multiplier may also be computed using the following formula:
Wastage multiplier = total number of doses per unit (ampule or vial)
-----------------------------------------------------------
number of doses used
o To convert vaccine requirement for the year to number of units (ampule or vial, or bottles)
divide by the number of doses per unit
Sample Computation:
To determine OPV requirement for a municipality with total population of 15,000:
Eligible population = 15,000 x.027
= 405 infants
OPV requirement = 405 infants x 3 doses for the year per infant x 1.67
= 2,029 doses
There are 20 doses/bottle of OPV. To convert doses to bottles:
Requirement for the year in bottles = Requirement for the year in doses
number of doses per bottle
= 2,029 doses
20 doses per bottle
= 101.45 bottles
If requisition of immunization supplies is done monthly, divide the number of bottles by 12
Monthly OPV requirement = 101.45 bottles
12
= 8.45 or 9 bottles per month
Note: A reserve stock of 25% of the supply period should be maintained at the facility
The Koch’s Phenomenon